Staphylococcus epidermidis: Emerging resistance and need for alternative agents

Clinical Infectious Diseases

Volumn 26, Issue 5, 1998, Pages 1182-1187

  Raad, Issam ^a,b   Alrahwan, Amin ^a   Rolston, Kenneth ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; GLYCOPEPTIDE; MINOCYCLINE; OXAZOLIDINONE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BIOFILM; COAGULASE NEGATIVE STAPHYLOCOCCUS; HOSPITAL INFECTION; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION;

EID: 0031926087     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520285     Document Type: Article

References (26)

1. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991;91(suppl 3B):72S-5S.
2. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1991;6:479-86.
3. Jones RN. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. Am J Med 1996;100(suppl 6A):3S-12S.
4. Archer GL. Staphylococcus epidermidis and other coagulase-negative staphylococci. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:1777-84.
5. Raad II, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992;15:197-210.
6. Schoenbaum SC, Gardner P, Shillito J. Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis 1975;131:543-52.
7. Inman RD, Gallegos KV, Brause BD, Redecha PB, Christian CL. Clinical and microbial features of prosthetic and joint infection. Am J Med 1984;77:47-53.
8. West TE, Walshe JJ, Krol CP, Asterdam D. Staphylococcal peritonitis in patients on continuous peritoneal dialysis. J Clin Microbiol 1986;23:809-12.
9. Bandyk DF, Berni GA, Thiele BL, Towne JB. Aorto-femoral graft infections due to Staphylococcus epidermidis. Arch Surg 1984;119:102-8.
10. Karchmer AW, Archer GL, Dismukes WE. Staphylococcus epidermidis prosthetic valve endocarditis: microbiological and clinical observations as guides to therapy. Ann Intern Med 1983;98:447-55.
11. Wade JC, Schimpff SC, Newman KA, Wiemik PH. Slaphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Ann Intern Med 1982;97:503-8.
12. Koll BS, Brown AE. The changing epidemiology of infections at cancer hospitals. Clin Infect Dis 1993;17(suppl 2):S322-8.
13. Anday EK, Talbot GH. Coagulase-negative Staphylococcus bacteremia -a rising threat in the newborn infant. Ann Clin Lab Sci 1985;15:246-51.
14. Weinstein RA, Kabins SA, Nathan C, Sweeney HM, Jaffe HW, Cohen S. Gentamicin-resistant staphylococci as hospital flora: epidemiology and resistant plasmids. J Infect Dis 1982;145:374-82.
15. Archer GL. Molecular epidemiology for multiresistant Staphylococcus epidermidis. J Antimicrob Chemother 1988;21(suppl):133-8.
16. Caputo GH, Archer G, Calderwood SB, DiNubile HJ, Karchmer AW. Native valve endocarditis due to coagulase-negative staphylococci: clinical and microbiologic features. Am J Med 1987;83:619-25.
17. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997;24:584-602.
18. Fidalgo S, Vásquez F, Mendoza MC, Pérez F, Méndez FJ. Bacteremia due to Staphylococcus epidermidis: microbiologic, epidemiologic, clinical, and prognostic features. Rev Infect Dis 1990;12:520-8.
19. Ringberg H, Thorén A, Bredberg A. Evaluation of coagulase-negative staphylococci in blood cultures: a prospective clinical and microbiological study. Scand J Infect Dis 1991;23:315-23.
20. Herwaldt LA, Geiss M, Kao C, Pfaller MA. The positive predictive value of isolating coagulase-negative staphylococci from blood cultures. Clin Infect Dis 1996;22:14-20.
21. Lowy FD, Wexler WA, Steigbigel NH. Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis. J Lab Clin Med 1982;100:94-8.
22. Berry A, Johnston JL, Archer GL. Imipenem therapy of experimental Staphylococcus epidermidis endocarditis. Antimicrob Agents Chemother 1986;29:748-52.
23. Moller JK. Drug resistance and plasmid profiles in Staphylococcus epidermidis in 1964 and 1986. J Hosp Infect 1988;12:19-27.
24. Fukuchi K. Surveillance of multidrug-resistant environmental bacteria. Rinsho Byori 1994;42:1111-8.
25. Mempel M, Feucht H, Ziebuhr W, Endres M, Laufs R, Gruter L. Lack of mecA transcription in slime-negative phase variants of methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother 1994;38:1251-5.
26. Kotilainen P, Nikoskelainen J, Huovinen P. Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. J Infect Dis 1990;161:41-4.